Page 25 - 2020 JSOM Winter
        P. 25
     advanced interventions and the casualty is in shock. These two   platforms. However, documentation on casualty evacuation
              more invasive procedures are recommended only when the ca-  (CASEVAC) platforms is still lacking. Thus, a CASEVAC data-
              sualty is in refractory shock, not as the initial treatment.  set was developed and maintained by the 160th Special Oper-
                                                                 ations Aviation Regiment (SOAR), a nonmedical, rotary-wing
              Keywords: guidelines; tension pneumothorax; Tactical Com-  aviation  unit, to  evaluate  and review  CASEVAC  missions
              bat Casualty Care
                                                                 conducted by their organization. Methods: A retrospective re-
                                                                 view and descriptive analysis were performed on data from
              2018;18(1):62–68                                   all documented CASEVAC missions conducted in Afghanistan
              Intramuscular Tranexamic Acid in Tactical and Combat Set-  by the 160th SOAR from January 2008 to May 2015. Doc-
              tings  Vu EN, Wan WC, Yeung TC, Callaway DW        umentation of care was originally performed in a narrative
              ABSTRACT: Background: Uncontrolled hemorrhage remains   after-action review (AAR) format. Unclassified, nonpersonally
              a leading cause of preventable death in tactical and combat set-  identifiable  data were  extracted  and transferred  from these
              tings. Alternate routes of delivery of tranexamic acid (TXA),   AARs into a  database for detailed analysis. Data points in-
              an adjunct in the management of hemorrhagic shock, are be-  cluded demographics, flight time, provider number and type,
              ing studied. A working group for the Committee for Tacti-  injury and outcome details, and medical interventions pro-
              cal Emergency Casualty Care reviewed the available evidence   vided by ground forces and CASEVAC personnel.  Results:
              on the potential role for intramuscular (IM) administration   There were 227 patients transported during 129 CASEVAC
              of TXA in nonhospital settings as soon as possible from the   missions conducted by the 160th SOAR. Three patients had
              point of injury. Methods: EMBASE and MEDLINE/PubMed   unavailable data, four had unknown injuries or illnesses, and
              databases were sequentially searched by medical librarians for   eight were military working dogs. Remaining were 207 trauma
              evidence of TXA use in the following contexts and/or using   casualties (96%) and five medical patients (2%). The mean
              the following keywords: prehospital, trauma, hemorrhagic   and median times of flight from the injury scene to hospital
              shock, optimal timing, optimal dose, safe volume, incidence of   arrival were less than 20 minutes. Of trauma casualties, most
              venous thromboembolism (VTE), IM bioavailability. Results:   were male US and coalition forces (n = 178; 86%). From this
              A total of 183 studies were reviewed. The strength of the avail-  population, injuries to the extremities (n = 139; 67%) were
              able data was variable, generally weak in quality, and included   seen most commonly. The primary mechanisms of injury were
              laboratory research, case reports, retrospective observational   gunshot wound (n = 89; 43%) and blast injury (n = 82; 40%).
              reviews,  and few  prospective  studies.  Current volume  and   The survival rate was 85% (n = 176) for those who incurred
              concentrations of available formulations of TXA make it, in   trauma. Of those who did not survive, most died before reach-
              theory, amenable to IM injection. Current best practice guide-  ing surgical care (26 of 31; 84%). Conclusion: Performance
              lines for large-volume injection (i.e., 5mL) support IM admin-  improvement efforts directed toward prehospital combat ca-
              istration in four locations in the adult human body. One case   sualty care can ameliorate survival on the battlefield. Because
              series suggests complete bioavailability of IM TXA in healthy   documentation of care is essential for conducting performance
              patients. Data are lacking on the efficacy and safety of IM   improvement, medical and nonmedical units must dedicate
              TXA in hemorrhagic shock. Conclusion: There is currently in-  time and efforts accordingly. Capturing and analyzing data
              sufficient evidence to support a strong recommendation for or   from combat missions can help refine tactics, techniques, and
              against IM administration of TXA in the combat setting; how-  procedures and more accurately define wartime personnel,
              ever, there is an abundance of literature demonstrating efficacy   training, and equipment requirements. This study is an exam-
              and safety of TXA use in a broad range of patient populations.   ple of how performance improvement can be initiated by a
              Balancing the available data and risk- benefit ratio, IM TXA   nonmedical unit conducting CASEVAC missions.
              should be considered a viable treatment option for tactical and   Keywords: casualty evacuations; CASEVAC; en route care;
              combat applications. Additional studies should focus on the   Tactical Combat Casualty Care; TCCC
              optimal dose and bioavailability of IM dosing of patients in
              hemorrhagic shock, with assessment of potential downstream   2019;19(1):70–74
              sequelae.
                                                                 Battlefield Analgesia: Adherence to Tactical Combat Casualty
              Keywords: intramuscular;  tranexamic acid; hemorrhagic   Care Guidelines  Schauer SG, Fisher AD, April MD, Carter
              shock; Tactical Combat Casualty Care; Tactical Emergency   R, Cunningham CW, Aden JK, Fernandez JD, DeLorenzo RA
              Casualty Care
                                                                 ABSTRACT: Background: Low rates of prehospital analgesia,
                                                                 as recommended by Tactical Combat Casualty Care (TCCC)
              2018;18(2):79–85                                   guidelines, have been demonstrated in the Joint Theaters com-
              Survey of Casualty Evacuation Missions Conducted by the   bat setting. The reasons for this remain unclear. This study
              160th Special Operations Aviation Regiment During the Af-  expands on previous reports by evaluating a larger prehospital
              ghanistan Conflict   Redman TT, Mayberry KE, Mora AG,   dataset for determinants of analgesia administration.  Meth-
              Benedict BA, Ross EM, Mapp JG, Kotwal RS           ods: This was part of an approved quality assurance project
              ABSTRACT:  Background: Historically, documentation of   evaluating adherence to TCCC guidelines across multiple
              prehospital combat casualty care has been relatively nonex-  modalities. Data were from the Prehospital Trauma Registry,
              istent. Without documentation, performance improvement   which existed from January 2013 through September 2014,
              of prehospital care and evacuation through data collection,   and comprises data from TCCC cards, Department of Defense
              consolidation, and scientific analyses cannot be adequately   1380 forms, and after-action reports to provide real-time feed-
              accomplished. During recent conflicts, prehospital documen-  back to units on prehospital medical care. Results: Of 705 total
              tation has received increased attention for point-of-injury care   patient encounters, there were 501 documented administra-
              as well as for care provided en route on medical evacuation   tions of analgesic medications given to 397 patients. Of these
                                                                 events, 242 (34.3%) were within TCCC guidelines. Special
                                                                                 Then and Now: 20 Years In Publication  |  23





